GRB7 as a Potential Cancer Biomarker
Author Information
Author(s): Muacevic Alexander, Adler John R, Attaelmanan Areig M, Alzubair Shyma, Ahmmed Abdalla S, Abdelgalil Ahmed, Ali Fatima, Khalafalla Amira S, Attaelmanan Gamila A, Alfaki Mohamed
Hypothesis
This study aimed to assess the diagnostic and prognostic relevance of GRB7 in a comprehensive pan-cancer analysis.
Conclusion
GRB7 shows potential as a biomarker in both diagnosing and predicting outcomes for various cancers.
Supporting Evidence
- GRB7 expression was significantly upregulated in several cancers including bladder and cervical cancers.
- High GRB7 expression was linked to better prognosis in kidney cancer but poorer prognosis in pancreatic cancer.
- GRB7 expression showed significant correlations with immune cell infiltration in kidney cancers.
Takeaway
GRB7 is a protein that can help doctors figure out if someone has certain types of cancer and how well they might do with treatment.
Methodology
GRB7 expression was evaluated using various bioinformatics databases and statistical analyses.
Limitations
The study relies on computational datasets, necessitating further wet lab experiments for validation.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website